Bone Growth Stimulator Market to Grow with a CAGR of 5.19% through 2030
The increasing prevalence of bone disorders is expected
to drive the growth of global bone growth stimulator in the forecast period,
2026-2030.
According to TechSci Research report, “Bone Growth
Stimulator Market - Global Industry Size, Share, Trends, Opportunity, and
Forecast, 2030”, the Global Bone Growth Stimulator Market was valued
at USD 1.24 billion in 2024 and is expected to reach USD 1.68 billion by 2030
with a CAGR of 5.19% during the forecast period. This can be
ascribed to the increasing demand for newly developed instruments for the
treatment of bone-related injuries and diseases across the globe. Additionally,
technological advancements in the end users for bone growth stimulators and the
introduction of new instruments especially in the developed countries in North
America and Europe, are expected to create lucrative opportunities for market
growth in coming years. Besides, increasing investment in research and demand
for manufacturing bone growth stimulators in underdeveloped and developing
countries is further expected to support the market growth. Additionally,
increasing agreements among major players along with the increased incidence of
spinal deformities will further boost market growth during the forecast period.
However, increasing usage of expensive systems and the high price of the
devices reduce the return on investment, thus, creating low adoption. This is
slowing down the growth of the global bone growth stimulator market
in the forecast period. Similarly, a dearth of professionals may hamper
the bone growth stimulators market growth during the forecast period.
The lack of awareness about new instruments for research and development in
emerging countries can further restrict the growth of the
global cell-based assays market.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Bone Growth Stimulator Market"
The global bone growth stimulator market is
segmented into type, application, end users, regional distribution, and
company.
Based on Application, Spinal Fusion Surgeries are showing
the fastest growth. This accelerated expansion is largely driven by the rising
prevalence of spinal disorders such as degenerative disc disease, herniated
discs, scoliosis, and spinal stenosis, along with increasing numbers of spinal
injuries due to aging populations and trauma cases. Spinal fusion is a complex
procedure that involves fusing two or more vertebrae to eliminate painful
motion or to stabilize a spinal deformity. However, it carries a risk of
delayed bone healing or non-union, especially in high-risk patients such as
smokers, diabetics, or elderly individuals. In such cases, bone growth
stimulators—particularly external and implanted devices—are increasingly
utilized to enhance osteogenesis and improve surgical
outcomes. Governments and health authorities are increasingly focusing on
reducing post-surgical complications, and the use of bone growth stimulation
devices in spinal fusion surgeries aligns with this priority. For instance, the
U.S. Centers for Medicare & Medicaid Services (CMS) often considers bone
stimulators in spinal fusion as a reimbursable therapeutic option under certain
conditions, which further supports market growth.
Based on the Region, Asia Pacific is witnessing the fastest
growth in the global Bone Growth Stimulator Market, driven by several dynamic
factors such as rising healthcare expenditure, growing awareness of advanced
bone healing technologies, and a rapidly expanding elderly population.
Countries like China, India, Japan, and South Korea are at the forefront of
this regional surge due to increasing orthopedic surgical procedures and
improved access to healthcare infrastructure. The region is experiencing a sharp
rise in musculoskeletal disorders due to an aging demographic, sedentary
lifestyle, and increasing incidences of road accidents and sports injuries.
According to the World Health Organization (WHO), by 2050, approximately 80% of
the world's older population will live in low- and middle-income countries,
many of which are in the Asia Pacific region. This demographic shift is
expected to significantly increase the demand for orthopedic interventions and
post-operative bone healing support. Government initiatives to enhance public
healthcare systems and the promotion of medical tourism in countries like
Thailand, India, and Malaysia further contribute to market growth. Patients are
increasingly opting for advanced treatments, including non-invasive bone growth
stimulators, due to shorter recovery times and reduced surgical risks.
Major companies operating in the Global Bone Growth
Stimulator Market are:
- Colfax
Corporation
- Arthrex
- Essex
Woodlands Healthcare Partners
- Isto
Biologics
- Johnson
and Johnson
- Medtronic
Plc
- Orthofix
Medical Inc.
- Stryker
Corporation
- Terumo
Corporation
- Zimmer
Biomet Holdings
Download Fee Sample Report
Customers can also request for 10% free customization
on this report.
“North America is expected to dominate in the Global Bone
Growth Stimulator market because of increasing healthcare expenditure,
increasing prevalence of different types of bone-related injuries along with
bone-related disorders across the region. Furthermore, growing demand for
painless treatment, greater affordability along with growing favorable
reimbursement policies for the treatment of different bone-related diseases are
further contributing to the demand for bone growth stimulators. Similarly,
growing non-union fractures and increasing preference for non-surgical
treatment procedures is expected to propel the market growth during forecast
period. Besides, increasing investment by government organizations for the
development of new bone growth stimulators in the region is further expected to
create lucrative opportunities for the market growth,” said Mr. Karan Chechi,
Research Director of TechSci Research, a research-based global management
consulting firm.
“Bone Growth Stimulator Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (External Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators, Implanted Bone Growth Stimulators), By Application (Spinal Fusion Surgeries, Delayed Union, and Non-union Bone Fractures, Oral and Maxillofacial Surgeries, Others), By End User (Hospital and Ambulatory Surgery Centers, Home Care Settings, Academic and Research Institutes), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of global bone
growth stimulator market and provides statistics & information on
market size, structure, and future market growth. The report intends to provide
cutting-edge market intelligence and help decision-makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in the Global Bone
Growth Stimulator market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com